SFE Investment Counsel Sells 239 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

SFE Investment Counsel lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 9.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,361 shares of the financial services provider’s stock after selling 239 shares during the period. SFE Investment Counsel’s holdings in iShares Biotechnology ETF were worth $312,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of IBB. Hudock Inc. acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $229,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $4,161,000. Certuity LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth $454,000. Comprehensive Financial Planning Inc. PA acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at $47,000. Finally, Angeles Wealth Management LLC boosted its holdings in shares of iShares Biotechnology ETF by 2,083.3% in the 4th quarter. Angeles Wealth Management LLC now owns 524 shares of the financial services provider’s stock valued at $69,000 after purchasing an additional 500 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.9 %

NASDAQ:IBB opened at $135.47 on Thursday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The stock’s 50-day simple moving average is $135.88 and its 200 day simple moving average is $141.13.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.